Status:
COMPLETED
Evaluation and Treatment of Heart Disease in Patients Not Participating in Research
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Arrhythmia
Congenital Heart Defect
Eligibility:
All Genders
Phase:
NA
Brief Summary
There is an important need to maintain clinical skills, provide quality training and expertise, and provide an environment that stimulates ideas for clinical research. This study permits inpatient ev...
Detailed Description
There is an important need to maintain clinical skills, to ensure adequate training and expertise, and provide an environment that stimulates ideas for clinical research. This protocol permits inpatie...
Eligibility Criteria
Patients with signs or symptoms of heart disease.
Patients selected because of either medical or research interest to the Principal Investigator.
Patients must not have unstable angina pectoris, unstable course following recent (within one month) myocardial infarction.
Must not be in New York Heart Association functional class IV heart failure.
A positive pregnancy test will obviate any cardiovascular testing requiring ionizing radiation.
Key Trial Info
Start Date :
January 1 1995
Trial Type :
INTERVENTIONAL
End Date :
April 1 2002
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00001460
Start Date
January 1 1995
End Date
April 1 2002
Last Update
March 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892